BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 3, 2020
View Archived Issues
Novel NLRP3 inflammasome inhibitors as potential treatments of chronic inflammatory diseases
Read More
First-in-human data reported for Ad5 vectored COVID-19 vaccine
Read More
General method for taking out specific Gram-negatives
Read More
Kinase helps prepare pre-metastatic niche
Read More
Proteostasis Therapeutics reports in vitro data on UPR modulator PTI-129 for COVID-19
Read More
Lilly initiates phase I study of LY-CoV555 for COVID-19
Read More
Sarclisa approved in Europe for adults with relapsed and refractory multiple myeloma
Read More
Danish Medical Agency approves CTA application for AP-1189 in nephrotic syndrome
Read More
Trevena and Imperial College London collaborate to evaluate TRV-027 in patients with COVID-19
Read More
Maximum tolerated dose identified with positive safety profile for CC-92480 in multiple myeloma
Read More
Nimbus Artemis describes new ATP-citrate synthase inhibitors
Read More
FDA clears IND application for SNK-01 in combination with trastuzumab or cetuximab
Read More
MAP3K5 inhibitors discovered at Enanta Pharmaceuticals
Read More
Preliminary safety data reported from ILLUMINATE-206 study
Read More
Bayer patents cytostatic conjugates with integrin alphavbeta3 ligands
Read More
Topline data from pivotal phase III True North trial of Zeposia in ulcerative colitis
Read More
New PI3K-gamma inhibitors disclosed by Incyte
Read More
Beijing Reciproca Pharmaceuticals identifies new Bruton tyrosine kinase inhibitors
Read More
Description of a potential COVID-19 mouse model presenting human ACE2 and TMPRSS2 genes
Read More
Efficacy and safety reported for alflutinib in NSCLC patients with EGFR T790M mutation
Read More
Tenax Therapeutics reports positive phase II results for levosimendan in PH-HFpEF
Read More
Topline data announced from phase IIb study of gusacitinib in chronic hand eczema
Read More
FDA gives clearance to phase I study of CK-0802 in COVID-19-associated ARDS
Read More
Favorable results seen with immunotherapy OH-2 in patients with advanced solid tumors
Read More
Enrollment starts in phase I study of WP-1066
Read More
First-in-human data presented for of SRF-231
Read More
FDA clears IND for phase I/II study of Altimmune's T-COVID
Read More
Intravacc and EpiVax collaborate to advance novel COVID-19 vaccine
Read More